Literature DB >> 8352281

Further localization of the gene for nevoid basal cell carcinoma syndrome (NBCCS) in 15 Australasian families: linkage and loss of heterozygosity.

G Chenevix-Trench1, C Wicking, J Berkman, H Sharpe, A Hockey, E Haan, C Oley, D Ravine, A Turner, D Goldgar.   

Abstract

Nevoid basal cell carcinoma syndrome (NBCCS; basal cell nevus syndrome or Gorlin syndrome) is a cancer-predisposition syndrome characterized by multiple basal cell carcinomas (BCCs) and diverse developmental defects. The gene for NBCCS has been mapped to 9q23.1-q31 in North American and European families. In addition, loss of heterozygosity (LOH) for genetic markers in this region has been detected in sporadic BCCs, indicating that the NBCCS gene is probably a tumor-suppressor gene. In this study we have determined that the NBCCS gene is also linked to this region in Australasian pedigrees and that there is no significant evidence of heterogeneity. We have defined the localization of the gene by multipoint and haplotype analysis of 15 families, using four microsatellite markers. LOH at these loci was detected in 50% of sporadic BCCs, a rate that is significantly higher than that in other skin lesions used as controls.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8352281      PMCID: PMC1682420     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  17 in total

1.  Localisation of gene for the naevoid basal-cell carcinoma syndrome.

Authors:  A Reis; W Küster; G Linss; E Gebel; H Hamm; W Fuhrmann; G Wolff; W Groth; G Gustafson; M Kuklik
Journal:  Lancet       Date:  1992-03-07       Impact factor: 79.321

2.  A dinucleotide repeat polymorphism at the D9S127 locus.

Authors:  J E Lyall; R A Furlong; M A Yuille; D R Goudie; M A Leversha; N A Affara; M A Ferguson-Smith
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

3.  A dinucleotide repeat polymorphism at the D9S109 locus.

Authors:  R A Furlong; J E Lyall; D R Goudie; M A Leversha; N A Affara; M A Ferguson-Smith
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

4.  Linkage map of human chromosome 9 microsatellite polymorphisms.

Authors:  P J Wilkie; D B Krizman; J L Weber
Journal:  Genomics       Date:  1992-03       Impact factor: 5.736

5.  Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique.

Authors:  S Levi; A Urbano-Ispizua; R Gill; D M Thomas; J Gilbertson; C Foster; C J Marshall
Journal:  Cancer Res       Date:  1991-07-01       Impact factor: 12.701

6.  Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms.

Authors:  P A Futreal; P Söderkvist; J R Marks; J D Iglehart; C Cochran; J C Barrett; R W Wiseman
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

7.  Cytogenetic analysis of 33 basal cell carcinomas.

Authors:  F Mertens; S Heim; N Mandahl; B Johansson; O Mertens; B Persson; L Salemark; J Wennerberg; N Jonsson; F Mitelman
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

8.  Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9.

Authors:  M R Gailani; S J Bale; D J Leffell; J J DiGiovanna; G L Peck; S Poliak; M A Drum; B Pastakia; O W McBride; R Kase
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

9.  Location of gene for Gorlin syndrome.

Authors:  P A Farndon; R G Del Mastro; D G Evans; M W Kilpatrick
Journal:  Lancet       Date:  1992-03-07       Impact factor: 79.321

Review 10.  The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma.

Authors:  D G Evans; P A Farndon; L D Burnell; H R Gattamaneni; J M Birch
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

View more
  12 in total

1.  Gorlin's syndrome with a thin corpus callosum and a third ventricular cyst.

Authors:  M Kantarci; U Ertas; F Alper; Y Sutbeyaz; R M Karasen; O Onbas
Journal:  Neuroradiology       Date:  2003-05-17       Impact factor: 2.804

2.  Molecular analysis of medulloblastomas occurring simultaneously in monozygotic twins.

Authors:  W Scheurlen; N Sörensen; W Roggendorf; J Kühl
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

3.  Localization of the gene for the nevoid basal cell carcinoma syndrome.

Authors:  A M Goldstein; C Stewart; A E Bale; S J Bale; M Dean
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

Review 4.  Nevoid basal cell carcinoma syndrome (Gorlin syndrome).

Authors:  Lorenzo Lo Muzio
Journal:  Orphanet J Rare Dis       Date:  2008-11-25       Impact factor: 4.123

5.  Mutational landscape of basal cell carcinomas by whole-exome sequencing.

Authors:  Shyam S Jayaraman; David J Rayhan; Salar Hazany; Michael S Kolodney
Journal:  J Invest Dermatol       Date:  2013-06-17       Impact factor: 8.551

6.  Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors.

Authors:  G Chenevix-Trench; J Kerr; M Friedlander; T Hurst; B Sanderson; M Coglan; B Ward; J Leary; S K Khoo
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

7.  Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas.

Authors:  D Schofield; D C West; D C Anthony; R Marshal; J Sklar
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

8.  A survey of phenotypic features in juvenile polyposis.

Authors:  D C Desai; V Murday; R K Phillips; K F Neale; P Milla; S V Hodgson
Journal:  J Med Genet       Date:  1998-06       Impact factor: 6.318

9.  Analysis of mutation in exon 17 of PTCH in patients with nevoid basal cell carcinoma syndrome.

Authors:  Jichen Li; Jinhui Wang; Yingqun Liu; Wei Wang
Journal:  Mol Biol Rep       Date:  2010-01       Impact factor: 2.316

10.  Differential allele loss on chromosome 9q22.3 in human non-melanoma skin cancer.

Authors:  E Holmberg; B L Rozell; R Toftgård
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.